About this trial
Millions have developed Long COVID (LC), and recent findings show an association between taurine deficiency (an amino acid) and symptoms in LC. Cost-effective and accessible interventions are needed to improve welfare and reduce healthcare costs. We will investigate the efficacy of 12-weeks of taurine supplementation (self-administered), on vascular function and the cardio/cerebrovascular responses to upright posture. We will measure resting vascular function with an EndoPAT device, resting heart rate variability, and the blood pressure, heart rate, and brain blood flow responses to 5 minutes of head-up tilt before and after weeks of taurine supplementation in LC. We hypothesize that the 12 weeks of supplementation will improve both resting vascular function and the responses to upright tilt. In turn, we hypothesize that symptoms will also improve (as measured by questionnaires).
Eligibility criteria
Qualifiers
Participants will have had symptoms of Long COVID post-infection for at least 3 months
Disqualifiers
Inability to undergo tilt table testing for 5 minutes
Inability to transport selves to York University from their homes
Inability to speak English, or provide a translator
Blood clotting disorders
Trial design
Treatments tested in this trial
- Taurine supplementation
Treatment groups
Sponsors and collaborators
York University
Lead sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator